Treosulfan/fludarabine-based conditioning for allogeneic stem cell transplant in high-risk haematologic malignancies. A 5-years single-centre experience

被引：0
|
作者：
Baronciani, D. [1 ,3 ]
Depau, C. [1 ,3 ]
Targhetta, C. [1 ,3 ]
Pilo, F. [1 ,3 ]
Derudas, D. [1 ,3 ]
Culurgioni, F. [1 ,3 ]
Pani, M. [2 ]
Angelucci, E. [1 ,3 ]
机构：
[1] UO Ematol, Cagliari, Italy
[2] AO Brotzu, Cagliari, Italy
[3] CTMO PO Businco, Cagliari, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S298 / S298
页数：1
相关论文
共 50 条
  • [31] ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT IN LYMPHOMA: A SINGLE-CENTRE EXPERIENCE; A CASE SERIES
    Baybay, Jan Miko Aaron
    Lopez, Francisco Vicente
    BONE MARROW TRANSPLANTATION, 2024, 59 : 494 - 494
  • [32] Sequential conditioning in high-risk leukaemia: a single-centre experience in 116 patients
    Kobbe, G.
    Kondakci, M.
    Czibere, A.
    Bruns, I.
    Balleisen, S.
    Fenk, R.
    Distelmeier, L.
    Graef, T.
    Germing, U.
    Haas, R.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S87 - S87
  • [33] Busulfan-fludarabine as myeloablative conditioning regimen in allogeneic stem cell transplantation: incidence of complications and outcome. A single-centre experience
    Parma, M.
    Pioltelli, P.
    Terruzzi, E.
    Bozzani, S.
    Pogliani, E.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S94 - S94
  • [34] Busulfan and Fludarabine As Conditioning Regimen for Unrelated Allogeneic Stem Cell Transplant: A Single-Center Experience
    Sutamtewagul, Grerk
    Abbi, Kamal Kant Singh
    Farooq, Umar
    Mott, Sarah L.
    Dozeman, Lindsay
    Silverman, Margarida
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S358 - S358
  • [35] Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience
    Clerici, D.
    Corti, C.
    Matteazzi, F.
    Greco, R.
    Assanelli, A.
    Lunghi, F.
    Malato, S.
    Giglio, F.
    Vago, L.
    Gentner, B.
    Fumagalli, L.
    Marcatti, M.
    Bernardi, M.
    Ciceri, F.
    Peccatori, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S228 - S228
  • [36] Allogeneic stem cell transplantation in patients with high-risk de novo or relapsed multiple myeloma. A single-centre experience
    Schonland, S. O.
    Gerull, S.
    Goerner, M.
    Moehler, T.
    Goldschmidt, H.
    Ho, A. D.
    Dreger, P.
    Hegenbart, U.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S152 - S153
  • [37] Impact of stem cell source on immunological reconstitution after allogeneic stem cell transplant:: a single-centre experience
    Lioznov, M.
    Dellbruegger, C.
    Sputtek, A.
    Fehse, B.
    Kroeger, N.
    Zander, A. R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S148 - S148
  • [38] Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide For Patients with High-Risk Hematologic Malignancies. A Single Center Experience in Mexico
    Aguado Vazquez, Tania Marcela
    Acosta Maldonado, Brenda Lizeth
    Valero Saldana, Luis Manuel
    Rivera Fong, Liliana Mey Len
    Garzon Velasquez, Katheryn Betsabe
    Moreira Ponce, Carolina
    Cervantes Perez, Lorena Alejandra
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 325 - 326
  • [39] Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience
    Nguyen, Phillip C.
    Muirhead, Jenny
    Tan, Joanne
    Kalff, Anna
    Bergin, Krystal
    Walker, Patricia
    Spencer, Andrew
    INTERNAL MEDICINE JOURNAL, 2022, 52 (07) : 1263 - 1267
  • [40] Non-myeloablative stem cell transplantation for the treatment of haematologic malignancies and metastatic solid tumours: a single-centre experience
    Cetin, M
    Altuntas, F
    Sari, I
    Eser, B
    Er, O
    Canoz, O
    Kaplan, B
    Ozkan, M
    Albayrak, E
    Bahar, S
    Ozkul, Y
    Patiroglu, T
    Unal, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S328 - S328
12345